Eye Health Academy

Despite advances in treatment for nAMD, visual outcomes remain suboptimal. How can we improve outcomes in our nAMD patients?

Meeting Eye-to-Eye: A Patient-Provider Exchange on Improving Treatment in nAMD Through Sustained Delivery The incidence of neovascular age-related macular degeneration (nAMD) is rising as a large segment of the US population ages. Despite recent advances in treatment, frequent injections and monitoring visits create a burden on patients that often leads to nonadherence, undertreatment, and suboptimal vi...